Tali Azenkot

Title(s)RESID PHYS/SUBSPEC 4-8/REP, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77. Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. PMID: 37801340.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Isolated Finger Compartment Syndrome Following Crush Injury. J Gen Intern Med. 2023 Dec; 38(16):3636-3637. Azenkot T, Aronowitz PB. PMID: 37723367; PMCID: PMC10713936.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis. Leuk Res. 2023 08; 131:107331. Khanna V, Azenkot T, Liu SQ, Gilbert J, Cheung E, Lau K, Pollyea DA, Traer E, Jonas BA, Zhang TY, Mannis GN. PMID: 37263072.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Tobacco and Cannabis Use During and After Pregnancy in California. Matern Child Health J. 2023 Jan; 27(1):21-28. Azenkot T, Dove MS, Fan C, Valencia CV, Tong EK, Schwarz EB. PMID: 36192518; PMCID: PMC9529159.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    5. Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia. Cancers (Basel). 2022 Jul 26; 14(15). Azenkot T, Jonas BA. PMID: 35892893; PMCID: PMC9330895.
      View in: PubMed   Mentions: 2  
    6. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res. 2022 08; 119:106885. Othman T, Moskoff BN, Ho G, Tenold ME, Azenkot T, Krackeler ML, Fisch SC, Potter LA, Kaesberg PR, Welborn JL, Wun T, Esteghamat NS, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 35738024.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Special Considerations for Women of Reproductive Age on Anticoagulation. J Gen Intern Med. 2022 08; 37(11):2803-2810. Azenkot T, Schwarz EB. PMID: 35641728; PMCID: PMC9411301.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Anticoagulant Prescriptions Provided in US Ambulatory Practice, 2014 to 2016. J Gen Intern Med. 2022 10; 37(13):3515-3517. Azenkot T, Chatterton B, Schwarz EB. PMID: 35411531; PMCID: PMC9550935.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia. Am J Hematol. 2022 06 01; 97(6):E191-E194. Kennedy VE, Hui G, Azenkot T, Gaut D, Wieduwilt MJ, Oliai C, Jonas BA, Mittal V, Logan AC, Muffly LS, Mannis GN. PMID: 35266185.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Hospital-acquired influenza in the United States, FluSurv-NET, 2011-2012 through 2018-2019. Infect Control Hosp Epidemiol. 2022 10; 43(10):1447-1453. Cummings CN, O'Halloran AC, Azenkot T, Reingold A, Alden NB, Meek JI, Anderson EJ, Ryan PA, Kim S, McMahon M, McMullen C, Spina NL, Bennett NM, Billing LM, Thomas A, Schaffner W, Talbot HK, George A, Reed C, Garg S. PMID: 34607624.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    11. An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia. Expert Rev Hematol. 2021 05; 14(5):407-417. Othman TA, Tenold ME, Moskoff BN, Azenkot T, Jonas BA. PMID: 34076549; PMCID: PMC8515853.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia. Future Oncol. 2021 Aug; 17(23):2989-3005. Othman TA, Azenkot T, Moskoff BN, Tenold ME, Jonas BA. PMID: 34024158.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    13. Cytomegalovirus shedding from breastmilk and mucosal sites in healthy postpartum women: A pilot study. J Med Virol. 2019 05; 91(5):894-898. Azenkot T, Zaniello B, Green ML, Selke S, Huang ML, Magaret A, Wald A, Johnston C. PMID: 30578684; PMCID: PMC6402967.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    14. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial. JCI Insight. 2017 04 06; 2(7):e91963. Gasper MA, Hesseling AC, Mohar I, Myer L, Azenkot T, Passmore JS, Hanekom W, Cotton MF, Crispe IN, Sodora DL, Jaspan HB. PMID: 28405623; PMCID: PMC5374072.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    15. Sugar-induced cephalic-phase insulin release is mediated by a T1r2+T1r3-independent taste transduction pathway in mice. Am J Physiol Regul Integr Comp Physiol. 2015 Sep; 309(5):R552-60. Glendinning JI, Stano S, Holter M, Azenkot T, Goldman O, Margolskee RF, Vasselli JR, Sclafani A. PMID: 26157055; PMCID: PMC4591378.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    Tali's Networks
    Concepts (104)
    Derived automatically from this person's publications.
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _